Results 151 to 160 of about 27,592 (211)

The role of early ezetimibe combination with atorvastatin in patients with atherosclerotic cardiovascular disease. [PDF]

BMC Cardiovasc Disord
Kang SH, Kwon SU, Lee JY, Seo SM, Nam CW, Park GM, Hong YJ, Lee WY, Jang JE, Chae IH.   +9 more
europepmc   +1 more source

Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus. [PDF]

Eur Heart J Cardiovasc Pharmacother
Drexel H, Festa A, Schmidt TA, Rocca B, Dobrev D, Agewall S, Tamargo J, Kaser S.   +7 more
europepmc   +1 more source

冠動脈疾患を有する患者において、エゼチミブの追加投与はエイコサペンタ酸の吸収に影響することなくsmall dense LDLコレステロール値を低下させる：パイロット研究 [PDF]

, 2015
Kubo, Motoki
core  

High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trial. [PDF]

BMJ Open
Choo EH, Kim CJ, Hwang BH, Lee KY, Oh GC, Lim S, Choi IJ, Kim DB, Kwon OS, Lee S, Choi Y, Park CS, Park MW, Kim HY, Lee HC, Kang TS, Sung JK, Woo SI, Park HS, Yun KH, Chang K, ROSUZET-AMI investigator.   +21 more
europepmc   +1 more source

Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study. [PDF]

Lipids Health Dis
Yang W, Lee YB, Kim EG, Cho HJ, Yu S, Kim JT, Shin JW, Lee SJ, Kim BJ, Hong JM, Koh SH, An SJ, Cho AH, Jung JM, Cho HJ, Kim C, Lee EJ, Kim JM, Lee SH.   +18 more
europepmc   +1 more source

LDL-C lowering in patients treated with bempedoic acid in a real-world cohort. [PDF]

Atheroscler Plus
Nelson J, Bloedon L, Lewandowski D, Vaduganathan M, Ajose M, Bonafede M, Sarnes E.   +6 more
europepmc   +1 more source

Potential lipid-lowering effects of preussin B on inhibition of intestinal cholesterol absorption: integrative mechanisms of action and proteomic analysis. [PDF]

Front Pharmacol
Ontawong A, Inchai J, Holasut P, Chiangjong W, Chieochansin T, Crucitti D, Orgueira AM, Rojanaverawong W, Saithong T, Tunkaew K, Wiriyawaree H, Thongpat K, Tadpetch K, Rukachaisirikul V, Vaddhanaphuti CS.   +14 more
europepmc   +1 more source

Sitosterolemia due to compound heterozygous mutations in ABCG5: a case report. [PDF]

J Med Case Rep
Wu LL, Zhang L, Tang TT, Zhou YY, Chang XX, Guo W, Yan HM, Lin HD.   +7 more
europepmc   +1 more source

Progress in risk assessment and management: Forecasting updates across international cholesterol guidelines. [PDF]

Am J Prev Cardiol
Razavi AC, Sokolsky M, Belanger M, Blazoski C, Spitz JA, Sperling LS, Blumenthal RS, Whelton SP.   +7 more
europepmc   +1 more source

Voriconazole-associated liver injury: clinical risk factor identification and predictive nomogram construction. [PDF]

Front Pharmacol
Feng D, Ma Y, Liu X, Tang S, Xiang S, Wang J, Li S.   +6 more
europepmc   +1 more source